Article thumbnail

Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol

By Melanie Kolz, Jens Baumert, Martina Müller, Natalie Khuseyinova, Norman Klopp, Barbara Thorand, Christine Meisinger, Christian Herder, Wolfgang Koenig and Thomas Illig
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.
  2. (2005). Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity
  3. (2004). Bierhaus A: Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes. Diabetes Care
  4. (1984). C: Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study,
  5. (1998). Crook MA: Is type II diabetes mellitus a disease of the innate immune system? Diabetologia
  6. (2000). Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.
  7. (2000). DA: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet
  8. (2002). DA: Toll-like receptor 4 polymorphisms and atherogenesis.
  9. (2001). Diabetes mellitus: a hypercoagulable state.
  10. (2006). Flier JS: TLR4 links innate immunity and fatty acid-induced insulin resistance.
  11. (2002). GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous.
  12. (2005). HE: KORA--a research platform for population based health research. Gesundheitswesen
  13. (2004). Illig T:
  14. (2006). JB: Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes.
  15. (2004). JL: Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes. Am Heart J
  16. (2003). Jukema JW: Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation
  17. (2002). Lowel H: Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med
  18. (2001). Mackman N: LPS induction of gene expression in human monocytes. Cell Signal
  19. (2005). Mandrup-Poulsen T: An immune origin of type 2 diabetes? Diabetologia
  20. (2003). Medzhitov R: Toll-like receptor signaling pathways. Science
  21. (2006). MF: Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol
  22. (2004). MW: Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med
  23. (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.
  24. (1994). Robust variance estimation for the case-cohort design. Biometrics
  25. (2003). SW: Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.
  26. (2003). The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes
  27. (2006). The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes. Diabetes Technol Ther
  28. (2001). Tolllike receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation
  29. (2003). Tontonoz P: Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell
  30. (2003). Witztum JL: Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells.
  31. (2001). WW: Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol